News Archives - Page 2 of 3 - Agile Biotics

Featured news

<img width="300" height="265" src="https://agilebiotics.com/wp-content/uploads/2020/04/corona-300x265.jpg" class="attachment-medium size-medium" alt="" srcset="https://agilebiotics.com/wp-content/uploads/2020/04/corona-300x265.jpg 300w, https://agilebiotics.com/wp-content/uploads/2020/04/corona.jpg 494w" sizes="(max-width: 300px) 100vw, 300px" />

AGILeBiotics contributes to fight against future pandemic infections (e.g. COVID-19)

7 April 2020

Today, COVID-19 is defining our lives. The coronavirus disease outbreak has caught us by surprise resulting in many causalities and

<img width="300" height="300" src="https://agilebiotics.com/wp-content/uploads/2019/06/Victor-Schut-300x300.jpg" class="attachment-medium size-medium" alt="" srcset="https://agilebiotics.com/wp-content/uploads/2019/06/Victor-Schut-300x300.jpg 300w, https://agilebiotics.com/wp-content/uploads/2019/06/Victor-Schut-150x150.jpg 150w, https://agilebiotics.com/wp-content/uploads/2019/06/Victor-Schut.jpg 400w" sizes="(max-width: 300px) 100vw, 300px" />

AGILeBiotics B.V. appoints new CEO Victor Schut

6 April 2020

Victor Schut has been appointed as the new Chief Executive Officer (CEO) of AGILeBiotics and co-founder Dr. Andreas A. Bastian

<img width="225" height="300" src="https://agilebiotics.com/wp-content/uploads/2019/12/Picture-for-Pitch-Event-225x300.jpg" class="attachment-medium size-medium" alt="" srcset="https://agilebiotics.com/wp-content/uploads/2019/12/Picture-for-Pitch-Event-225x300.jpg 225w, https://agilebiotics.com/wp-content/uploads/2019/12/Picture-for-Pitch-Event-768x1024.jpg 768w, https://agilebiotics.com/wp-content/uploads/2019/12/Picture-for-Pitch-Event.jpg 972w" sizes="(max-width: 225px) 100vw, 225px" />

AGILeBiotics won the Investors Forum 2019 at the Dutch Life Sciences Conference

28 November 2019

We are proud to announce that AGILeBiotics is the winner of the Investors Forum 2019, which took place at the

<img width="300" height="300" src="https://agilebiotics.com/wp-content/uploads/2019/12/EUSMI-logo_1-300x300.jpg" class="attachment-medium size-medium" alt="" srcset="https://agilebiotics.com/wp-content/uploads/2019/12/EUSMI-logo_1-300x300.jpg 300w, https://agilebiotics.com/wp-content/uploads/2019/12/EUSMI-logo_1-150x150.jpg 150w, https://agilebiotics.com/wp-content/uploads/2019/12/EUSMI-logo_1.jpg 400w" sizes="(max-width: 300px) 100vw, 300px" />

AGILeBiotics has been awarded the EUSMI-H2020 grant for up-scale synthesis of pre-clinical antibiotic candidate Toframicin

14 October 2019

We are proud to announce that AGILeBiotics has been awarded the European Soft Matter Infrastructure (EUSMI) grant from from the

AGILeBiotics has received the Lead Development Voucher from the Netherlands Antibiotic Development Platform

12 July 2019

We are proud to announce that AGILeBiotics has been awarded the Lead Development Voucher by the Netherlands Antibiotic Development Platform

AGILeBiotics acquires first round of equity investment

1 March 2017

AGILeBiotics receives a pre-seed investment from three local investors, i.e. RUG Houdstermaatschappij BV Stichting Ir G.J. Smid Fonds BV Hanzepoort

Latest news

AGILeBiotics is now member of HollandBIO

27 June 2019

AGILeBiotics is welcoming new team members

20 June 2019

AGILeBiotics has received the Intellectual Property Voucher from the Netherlands Antibiotic Development Platform

28 February 2019

AGILeBiotics became a member of the BEAM Alliance

15 October 2018

We are attending BioPharm America in Boston 2018

4 September 2018

Archives

Share this page

About

AGILeBiotics B.V. is a pharmaceutical company focusing on the development of novel antibiotics for the treatment of multi-drug resistant infections

Latest news

<img width="300" height="265" src="https://agilebiotics.com/wp-content/uploads/2020/04/corona-300x265.jpg" class="attachment-medium size-medium" alt="" srcset="https://agilebiotics.com/wp-content/uploads/2020/04/corona-300x265.jpg 300w, https://agilebiotics.com/wp-content/uploads/2020/04/corona.jpg 494w" sizes="(max-width: 300px) 100vw, 300px" />

AGILeBiotics contributes to fight against future pandemic infections (e.g. COVID-19)

7 April 2020

<img width="300" height="300" src="https://agilebiotics.com/wp-content/uploads/2019/06/Victor-Schut-300x300.jpg" class="attachment-medium size-medium" alt="" srcset="https://agilebiotics.com/wp-content/uploads/2019/06/Victor-Schut-300x300.jpg 300w, https://agilebiotics.com/wp-content/uploads/2019/06/Victor-Schut-150x150.jpg 150w, https://agilebiotics.com/wp-content/uploads/2019/06/Victor-Schut.jpg 400w" sizes="(max-width: 300px) 100vw, 300px" />

AGILeBiotics B.V. appoints new CEO Victor Schut

6 April 2020

<img width="225" height="300" src="https://agilebiotics.com/wp-content/uploads/2019/12/Picture-for-Pitch-Event-225x300.jpg" class="attachment-medium size-medium" alt="" srcset="https://agilebiotics.com/wp-content/uploads/2019/12/Picture-for-Pitch-Event-225x300.jpg 225w, https://agilebiotics.com/wp-content/uploads/2019/12/Picture-for-Pitch-Event-768x1024.jpg 768w, https://agilebiotics.com/wp-content/uploads/2019/12/Picture-for-Pitch-Event.jpg 972w" sizes="(max-width: 225px) 100vw, 225px" />

AGILeBiotics won the Investors Forum 2019 at the Dutch Life Sciences Conference

28 November 2019

<img width="300" height="300" src="https://agilebiotics.com/wp-content/uploads/2019/12/EUSMI-logo_1-300x300.jpg" class="attachment-medium size-medium" alt="" srcset="https://agilebiotics.com/wp-content/uploads/2019/12/EUSMI-logo_1-300x300.jpg 300w, https://agilebiotics.com/wp-content/uploads/2019/12/EUSMI-logo_1-150x150.jpg 150w, https://agilebiotics.com/wp-content/uploads/2019/12/EUSMI-logo_1.jpg 400w" sizes="(max-width: 300px) 100vw, 300px" />

AGILeBiotics has been awarded the EUSMI-H2020 grant for up-scale synthesis of pre-clinical antibiotic candidate Toframicin

14 October 2019

Copyright © 2018 AGILeBiotics | All Rights Reserved. | Webdevelopment Skitter